Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Christine E. Napier is active.

Publication


Featured researches published by Christine E. Napier.


Nature Structural & Molecular Biology | 2009

Spontaneous occurrence of telomeric DNA damage response in the absence of chromosome fusions

Anthony J. Cesare; Zeenia Kaul; Scott B. Cohen; Christine E. Napier; Hilda A. Pickett; Axel A. Neumann; Roger R. Reddel

Telomere dysfunction is typically studied under conditions in which a component of the six-subunit shelterin complex that protects chromosome ends is disrupted. The nature of spontaneous telomere dysfunction is less well understood. Here we report that immortalized human cell lines lacking wild-type p53 function spontaneously show many telomeres with a DNA damage response (DDR), commonly affecting only one sister chromatid and not associated with increased chromosome end-joining. DDR+ telomeres represent an intermediate configuration between the fully capped and uncapped (fusogenic) states. In telomerase activity–positive (TA+) cells, DDR is associated with low TA and short telomeres. In cells using the alternative lengthening of telomeres mechanism (ALT+), DDR is partly independent of telomere length, mostly affects leading strand–replicated telomeres, and can be partly suppressed by TRF2 overexpression. In ALT+ (but not TA+) cells, DDR+ telomeres preferentially associate with large foci of extrachromosomal telomeric DNA and recombination proteins. DDR+ telomeres therefore arise through different mechanisms in TA+ and ALT+ cells and have different consequences.


PLOS ONE | 2012

Loss of wild-type ATRX expression in somatic cell hybrids segregates with activation of Alternative Lengthening of Telomeres.

Kylie Bower; Christine E. Napier; Sara L. Cole; Rebecca A. Dagg; Loretta Lau; Emma L. Duncan; Elsa L. Moy; Roger R. Reddel

Alternative Lengthening of Telomeres (ALT) is a non-telomerase mechanism of telomere lengthening that occurs in about 10% of cancers overall and is particularly common in astrocytic brain tumors and specific types of sarcomas. Somatic cell hybridization analyses have previously shown that normal telomerase-negative fibroblasts and telomerase-positive immortalized cell lines contain repressors of ALT activity, indicating that activation of ALT results from loss of one or more unidentified repressors. More recently, ATRX or DAXX was shown to be mutated both in tumors with telomere lengths suggestive of ALT activity and in ALT cell lines. Here, an ALT cell line was separately fused to each of four telomerase-positive cell lines, and four or five independent hybrid lines from each fusion were examined for expression of ATRX and DAXX and for telomere lengthening mechanism. The hybrid lines expressed either telomerase or ALT, with the other mechanism being repressed. DAXX was expressed normally in all parental cell lines and in all of the hybrids. ATRX was expressed normally in each of the four telomerase-positive parental cell lines and in every telomerase-positive hybrid line, and was abnormal in the ALT parental cells and in all but one of the ALT hybrids. This correlation between ALT activity and loss of ATRX expression is consistent with ATRX being a repressor of ALT.


BioTechniques | 2012

Enhanced isolation of fibroblasts from human skin explants

Lily I. Huschtscha; Christine E. Napier; Jane R. Noble; Kylie Bower; Amy Y.M. Au; Hamish Campbell; Antony W. Braithwaite; Roger R. Reddel

Here we describe a method for growing fibroblasts from human skin explants that increases the number of cells obtained by up to two orders of magnitude, thus increasing the amount of material available for research and diagnostic purposes and potentially for cell-based therapies. Explants can be transferred sequentially up to 80 times, if required, at which point the explants appear to be completely depleted of fibroblasts. Utilizing skin samples obtained from 16 donors, aged 18-66 years old, the first 20 transfers produced cultures with lifespan and growth characteristics that were all very similar to each other, but the cultures derived from later transfers had a decreasing replicative capacity. Final cumulative population doublings did not correlate with donor age, but correlated positively with the telomere length at early passage. We also demonstrated that explants can be transduced directly by lentiviral infection, and that cryopreserved tissue can be explanted successfully using this procedure.


Methods | 2017

Comparative analysis of whole genome sequencing-based telomere length measurement techniques.

Michael Lee; Christine E. Napier; Sile F. Yang; Jonathan W. Arthur; Roger R. Reddel; Hilda A. Pickett

Telomeres are regions of repetitive DNA at the ends of human chromosomes that function to maintain the integrity of the genome. Telomere attrition is associated with cellular ageing, whilst telomere maintenance is a prerequisite for malignant transformation. Whole genome sequencing (WGS) captures sequence information from the entire genome, including the telomeres, and is increasingly being applied in research and in the clinic. Several bioinformatics tools have been designed to determine telomere content and length from WGS data, and include Motif_counter, TelSeq, Computel, qMotif, and Telomerecat. These tools utilise different approaches to identify, quantify and normalise telomeric reads; however, it is not known how they compare to one another. Here we describe the details and utility of each tool, and directly compare WGS telomere length output with laboratory-based telomere length measurements. In addition, we evaluate the accessibility, practicality, speed, and additional features of each tool. Each tool was tested using a range of telomere read extraction criteria, to determine the optimal parameters for the specific WGS read length. The aim of this article is to improve the accessibility of WGS telomere length measurement tools, which have the potential to be applied to WGS cohorts for clinical as well as research benefit.


Scientific Reports | 2017

MatCol: a tool to measure fluorescence signal colocalisation in biological systems

Matloob Khushi; Christine E. Napier; Christine M. Smyth; Roger R. Reddel; Jonathan W. Arthur

Protein colocalisation is often studied using pixel intensity-based coefficients such as Pearson, Manders, Li or Costes. However, these methods cannot be used to study object-based colocalisations in biological systems. Therefore, a novel method is required to automatically identify regions of fluorescent signal in two channels, identify the co-located parts of these regions, and calculate the statistical significance of the colocalisation. We have developed MatCol to address these needs. MatCol can be used to visualise protein and/or DNA colocalisations and fine tune user-defined parameters for the colocalisation analysis, including the application of median or Wiener filtering to improve the signal to noise ratio. Command-line execution allows batch processing of multiple images. Users can also calculate the statistical significance of the observed object colocalisations compared to overlap by random chance using Student’s t-test. We validated MatCol in a biological setting. The colocalisations of telomeric DNA and TRF2 protein or TRF2 and PML proteins in >350 nuclei derived from three different cell lines revealed a highly significant correlation between manual and MatCol identification of colocalisations (linear regression R2 = 0.81, P < 0.0001). MatCol has the ability to replace manual colocalisation counting, and the potential to be applied to a wide range of biological areas.


Nucleic Acids Research | 2018

Telomere sequence content can be used to determine ALT activity in tumours

Michael Lee; Erdahl Teber; Oliver Holmes; Katia Nones; Ann-Marie Patch; Rebecca A. Dagg; Loretta Lau; Joyce Hy Lee; Christine E. Napier; Jonathan W. Arthur; Sean M. Grimmond; Nicholas K. Hayward; Peter A. Johansson; Graham J. Mann; Richard A. Scolyer; James S. Wilmott; Roger R. Reddel; John V. Pearson; Nicola Waddell; Hilda A. Pickett

Abstract The replicative immortality of human cancer cells is achieved by activation of a telomere maintenance mechanism (TMM). To achieve this, cancer cells utilise either the enzyme telomerase, or the Alternative Lengthening of Telomeres (ALT) pathway. These distinct molecular pathways are incompletely understood with respect to activation and propagation, as well as their associations with clinical outcomes. We have identified significant differences in the telomere repeat composition of tumours that use ALT compared to tumours that do not. We then employed a machine learning approach to stratify tumours according to telomere repeat content with an accuracy of 91.6%. Importantly, this classification approach is applicable across all tumour types. Analysis of pathway mutations that were under-represented in ALT tumours, across 1,075 tumour samples, revealed that the autophagy, cell cycle control of chromosomal replication, and transcriptional regulatory network in embryonic stem cells pathways are involved in the survival of ALT tumours. Overall, our approach demonstrates that telomere sequence content can be used to stratify ALT activity in cancers, and begin to define the molecular pathways involved in ALT activation.


Abstracts: AACR Precision Medicine Series: Opportunities and Challenges of Exploiting Synthetic Lethality in Cancer; January 4-7, 2017; San Diego, CA | 2017

Abstract A22: Synthetic lethality of cytolytic HSV-1 in cancer cells with ATRX and PML deficiency

Mingqi Han; Christine E. Napier; Sonja Frölich; Roger D. Everett; Anthony J. Cesare; Roger R. Reddel

In human somatic cells, telomeres shorten every cell division due to the end replication problem. Once reaching a critically short length, the cells will undergo permanent cell cycle arrest and become senescent. Cancer cells acquire unlimited proliferation ability by activation of a telomere maintenance mechanism, either the enzyme telomerase or the homologous recombination-based mechanism Alternative Lengthening of Telomeres (ALT). Cancers that utilize the ALT mechanism commonly are deficient for ATRX protein expression, are difficult to treat, and have a poor prognosis. We discovered that ICP0-null herpes simplex virus type 1 (HSV-1) was ten to one thousand-fold more effective in killing cancer cell lines that are ATRX-deficient. Sensitivity to mutant HSV-1 infection resulted from ATRX-dependent regulation of PML expression at both the transcriptional and post-transcriptional levels. Reduction of PML protein resulted in a concomitant reduction in PML nuclear bodies, which weakened the innate cellular immunity to viral infection. Infection of co-cultured primary and ATRX-null cancer cells revealed that mutant ICP0-null HSV-1 treatment preferentially killed ATRX-null cells. Our results suggest that mutant ICP0-null HSV-1 may have therapeutic benefit against ATRX-null cells. Moreover, these data provide an applicable approach for predicting, based on tumor ATRX or PML protein status, which tumors will respond to an oncolytic herpes virus. Citation Format: Mingqi Han, Christine E. Napier, Sonja Frolich, Roger D. Everett, Anthony J. Cesare, Roger R. Reddel. Synthetic lethality of cytolytic HSV-1 in cancer cells with ATRX and PML deficiency [abstract]. In: Proceedings of the AACR Precision Medicine Series: Opportunities and Challenges of Exploiting Synthetic Lethality in Cancer; Jan 4-7, 2017; San Diego, CA. Philadelphia (PA): AACR; Mol Cancer Ther 2017;16(10 Suppl):Abstract nr A22.


Oncotarget | 2015

ATRX represses alternative lengthening of telomeres.

Christine E. Napier; Lily I. Huschtscha; Adam Harvey; Kylie Bower; Jane R. Noble; Eric A. Hendrickson; Roger R. Reddel


Cell Reports | 2017

Extensive Proliferation of Human Cancer Cells with Ever-Shorter Telomeres

Rebecca A. Dagg; Hilda A. Pickett; Axel A. Neumann; Christine E. Napier; Jeremy D. Henson; Erdahl Teber; Jonathan W. Arthur; C. Patrick Reynolds; Jayne Murray; Michelle Haber; Alexander P. Sobinoff; Loretta Lau; Roger R. Reddel


Molecular Human Reproduction | 2016

DNA methylation mediated up-regulation of TERRA non-coding RNA is coincident with elongated telomeres in the human placenta

Boris Novakovic; Christine E. Napier; Regan Vryer; Eva Dimitriadis; Ursula Manuelpillai; Andrew M. Sharkey; Jeffrey M. Craig; Roger R. Reddel; Richard Saffery

Collaboration


Dive into the Christine E. Napier's collaboration.

Top Co-Authors

Avatar

Roger R. Reddel

Children's Medical Research Institute

View shared research outputs
Top Co-Authors

Avatar

Hilda A. Pickett

Children's Medical Research Institute

View shared research outputs
Top Co-Authors

Avatar

Jonathan W. Arthur

Children's Medical Research Institute

View shared research outputs
Top Co-Authors

Avatar

Axel A. Neumann

Children's Medical Research Institute

View shared research outputs
Top Co-Authors

Avatar

Kylie Bower

Children's Medical Research Institute

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Rebecca A. Dagg

Children's Hospital at Westmead

View shared research outputs
Top Co-Authors

Avatar

Anthony J. Cesare

Children's Medical Research Institute

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Jane R. Noble

Children's Medical Research Institute

View shared research outputs
Researchain Logo
Decentralizing Knowledge